SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000919574-21-000006
Filing Date
2021-01-04
Accepted
2021-01-04 11:15:27
Documents
1
Group Members
BROADFIN CAPITAL, LLCBROADFIN HEALTHCARE MASTER FUND, LTD.KEVIN KOTLER

Document Format Files

Seq Description Document Type Size
1 d8591586_13g-a.htm SC 13G/A 169765
  Complete submission text file 0000919574-21-000006.txt   171343
Mailing Address 4747 EXECUTIVE DRIVE, SUITE 240 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE, SUITE 240 SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Subject) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-44849 | Film No.: 21500623
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 300 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022 212-808-2460
Broadfin Capital, LLC (Filed by) CIK: 0001511901 (see all company filings)

IRS No.: 202924429 | Fiscal Year End: 1231
Type: SC 13G/A